{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:17:29Z","timestamp":1792480649044,"version":"4.5.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteoarthritis (OA) is defined as a degenerative joint disease that can affect all tissues of the joint, including the articular cartilage, subchondral bone, ligaments capsule, and synovial membrane. The conventional nonoperative treatments are ineffective for cartilage repair and induce only symptomatic relief. Platelet-rich plasma (PRP) is a platelet concentrate derived from autologous whole blood with a high concentration of platelets, which can exert anti-inflammatory and regenerative effects by releasing multiple growth factors and cytokines. Recent studies have shown that PRP exhibits clinical benefits in patients with OA. However, high operational and equipment requirements greatly limit the application of PRP to OA treatment. Past studies have indicated that high-concentration PRP growth factors and cytokines may be applied as a commercial replacement for PRP. We reviewed the relevant articles to summarize the feasibility and mechanisms of PRP-based growth factors in OA. The available evidence suggests that transforming growth factor-\u03b1 and \u03b2, platelet-derived growth factors, epidermal growth factor, insulin-like growth factor-1, and connective tissue growth factors might benefit OA, while vascular endothelial growth factor, tumor necrosis factor-\u03b1, angiopoietin-1, and stromal cell derived factor-1\u03b1 might induce negative effects on OA. The effects of fibroblast growth factor, hepatocyte growth factor, platelet factor 4, and keratinocyte growth factor on OA remain uncertain. Thus, it can be concluded that not all cytokines released by PRP are beneficial, although the therapeutic action of PRP has a valuable potential to improve.<\/jats:p>","DOI":"10.1186\/s13018-023-04119-3","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T23:27:12Z","timestamp":1695338832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhengchao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokai","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"issue":"10182","key":"4119_CR1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745\u201359.","journal-title":"Lancet"},{"key":"4119_CR2","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","volume":"2","author":"J Martel-Pelletier","year":"2016","unstructured":"Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl AJ, Pelletier JP. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"4119_CR3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","volume":"18","author":"W Zhang","year":"2010","unstructured":"Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil. 2010;18(4):476\u201399.","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"4119_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","volume":"44","author":"O Bruy\u00e8re","year":"2014","unstructured":"Bruy\u00e8re O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253\u201363.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"4119_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465\u201374.","journal-title":"Arthritis Care Res"},{"issue":"2","key":"4119_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1573397113666170829155149","volume":"14","author":"W Hermann","year":"2018","unstructured":"Hermann W, Lambova S, Muller-Ladner U. Current treatment options for osteoarthritis. Curr Rheumatol Rev. 2018;14(2):108\u201316.","journal-title":"Curr Rheumatol Rev"},{"issue":"4","key":"4119_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40520-020-01515-1","volume":"32","author":"NR Fuggle","year":"2020","unstructured":"Fuggle NR, Cooper C, Oreffo ROC, Price AJ, Kaux JF, Maheu E, Cutolo M, Honvo G, Conaghan PG, Berenbaum F, et al. Alternative and complementary therapies in osteoarthritis and cartilage repair. Aging Clin Exp Res. 2020;32(4):547\u201360.","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"4119_CR8","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3390\/biomedicines10092134","volume":"10","author":"A Gupta","year":"2022","unstructured":"Gupta A, Jeyaraman M, Maffulli N. Common medications which should be stopped prior to platelet-rich plasma injection. Biomedicines. 2022;10(9):2134.","journal-title":"Biomedicines"},{"issue":"18","key":"4119_CR9","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.3390\/ijms20184581","volume":"20","author":"I Andia","year":"2019","unstructured":"Andia I, Maffulli N. Blood-derived products for tissue repair\/regeneration. Int J Mol Sci. 2019;20(18):4581.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4119_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10195-018-0505-z","volume":"19","author":"I Andia","year":"2018","unstructured":"Andia I, Maffulli N. Some patients (and some of us) respond better to some biological therapies: the as yet unsolved conundrum. J Orthop Traumatol: Off J Italian Soc Orthop Traumatol. 2018;19(1):1.","journal-title":"J Orthop Traumatol: Off J Italian Soc Orthop Traumatol"},{"issue":"4","key":"4119_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bone.2003.12.010","volume":"34","author":"G Weibrich","year":"2004","unstructured":"Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004;34(4):665\u201371.","journal-title":"Bone"},{"issue":"2","key":"4119_CR12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0501.2005.01203.x","volume":"17","author":"F Graziani","year":"2006","unstructured":"Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implant Res. 2006;17(2):212\u20139.","journal-title":"Clin Oral Implant Res"},{"issue":"5","key":"4119_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tibtech.2006.02.010","volume":"24","author":"E Anitua","year":"2006","unstructured":"Anitua E, S\u00e1nchez M, Nurden AT, Nurden P, Orive G, And\u00eda I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24(5):227\u201334.","journal-title":"Trends Biotechnol"},{"issue":"20","key":"4119_CR14","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.3390\/ijms21207794","volume":"21","author":"P Everts","year":"2020","unstructured":"Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4119_CR15","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s00167-016-4261-4","volume":"26","author":"G Filardo","year":"2018","unstructured":"Filardo G, Di Matteo B, Kon E, Merli G, Marcacci M. Platelet-rich plasma in tendon-related disorders: results and indications. Knee Surg Sports Traumatol Arthroscop: Off J ESSKA. 2018;26(7):1984\u201399.","journal-title":"Knee Surg Sports Traumatol Arthroscop: Off J ESSKA"},{"issue":"6","key":"4119_CR16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0040-1709170","volume":"81","author":"Z Xuan","year":"2020","unstructured":"Xuan Z, Yu W, Dou Y, Wang T. Efficacy of platelet-rich plasma for low back pain: a systematic review and meta-analysis. J Neurol Surg Part A, Cent Eur Neurosurg. 2020;81(6):529\u201334.","journal-title":"J Neurol Surg Part A, Cent Eur Neurosurg"},{"issue":"6","key":"4119_CR17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2217\/rme-2018-0042","volume":"13","author":"I Andia","year":"2018","unstructured":"Andia I, Maffulli N. A contemporary view of platelet-rich plasma therapies: moving toward refined clinical protocols and precise indications. Regen Med. 2018;13(6):717\u201328.","journal-title":"Regen Med"},{"issue":"1","key":"4119_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0363546520909397","volume":"49","author":"JW Belk","year":"2021","unstructured":"Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med. 2021;49(1):249\u201360.","journal-title":"Am J Sports Med"},{"issue":"1","key":"4119_CR19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12891-020-03262-w","volume":"21","author":"J Zhao","year":"2020","unstructured":"Zhao J, Huang H, Liang G, Zeng LF, Yang W, Liu J. Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020;21(1):224.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"4119_CR20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00402-020-03551-y","volume":"141","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Driessen A, Quack V, Sippel N, Cooper B, Mansy YE, Tingart M, Eschweiler J. Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: a Bayesian network meta-analysis. Arch Orthop Trauma Surg. 2021;141(9):1473\u201390.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"15","key":"4119_CR21","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1111\/jcmm.16779","volume":"25","author":"P Zhu","year":"2021","unstructured":"Zhu P, Wang Z, Sun Z, Liao B, Cai Y. Recombinant platelet-derived growth factor-BB alleviates osteoarthritis in a rat model by decreasing chondrocyte apoptosis in vitro and in vivo. J Cell Mol Med. 2021;25(15):7472\u201384.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4119_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/gerona\/glac118","volume":"78","author":"Y Cai","year":"2023","unstructured":"Cai Y, Wang Z, Liao B, Sun Z, Zhu P. Anti-inflammatory and chondroprotective effects of platelet-derived growth factor-BB on osteoarthritis rat models. J Gerontol: Ser A. 2023;78(1):51\u20139.","journal-title":"J Gerontol: Ser A"},{"issue":"14","key":"4119_CR23","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.febslet.2012.05.028","volume":"586","author":"AP Hinck","year":"2012","unstructured":"Hinck AP. Structural studies of the TGF-\u03b2s and their receptors - insights into evolution of the TGF-\u03b2 superfamily. FEBS Lett. 2012;586(14):1860\u201370.","journal-title":"FEBS Lett"},{"issue":"6","key":"4119_CR24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685\u2013700.","journal-title":"Cell"},{"issue":"1","key":"4119_CR25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4049\/jimmunol.169.1.507","volume":"169","author":"A Scharstuhl","year":"2002","unstructured":"Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol. 2002;169(1):507\u201314.","journal-title":"J Immunol"},{"issue":"2","key":"4119_CR26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/joca.2000.0368","volume":"9","author":"AC Bakker","year":"2001","unstructured":"Bakker AC, van de Loo FA, van Beuningen HM, Sime P, van Lent PL, van der Kraan PM, Richards CD, van den Berg WB. Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarth Cartil. 2001;9(2):128\u201336.","journal-title":"Osteoarth Cartil"},{"issue":"6","key":"4119_CR27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm.3143","volume":"19","author":"G Zhen","year":"2013","unstructured":"Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, Askin FB, Frassica FJ, Chang W, Yao J, et al. Inhibition of TGF-\u03b2 signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med. 2013;19(6):704\u201312.","journal-title":"Nat Med"},{"issue":"8","key":"4119_CR28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00296-015-3251-z","volume":"35","author":"G Zhai","year":"2015","unstructured":"Zhai G, Dor\u00e9 J, Rahman P. TGF-\u03b2 signal transduction pathways and osteoarthritis. Rheumatol Int. 2015;35(8):1283\u201392.","journal-title":"Rheumatol Int"},{"issue":"24","key":"4119_CR29","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1080\/15384101.2018.1556063","volume":"17","author":"R Wang","year":"2018","unstructured":"Wang R, Xu B, Xu H. TGF-\u03b21 promoted chondrocyte proliferation by regulating Sp1 through MSC-exosomes derived miR-135b. Cell Cycle. 2018;17(24):2756\u201365.","journal-title":"Cell Cycle"},{"issue":"1","key":"4119_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00441-020-03319-1","volume":"384","author":"R Wang","year":"2021","unstructured":"Wang R, Xu B. TGF-\u03b21-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6. Cell Tissue Res. 2021;384(1):113\u201327.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"4119_CR31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40729-016-0052-4","volume":"2","author":"H Masuki","year":"2016","unstructured":"Masuki H, Okudera T, Watanebe T, Suzuki M, Nishiyama K, Okudera H, Nakata K, Uematsu K, Su CY, Kawase T. Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF). Int J Implant Dent. 2016;2(1):19.","journal-title":"Int J Implant Dent"},{"issue":"4","key":"4119_CR32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2004.03.007","volume":"15","author":"L Fredriksson","year":"2004","unstructured":"Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004;15(4):197\u2013204.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"4119_CR33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4065\/81.9.1241","volume":"81","author":"RH Alvarez","year":"2006","unstructured":"Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc. 2006;81(9):1241\u201357.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4119_CR34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0014-4827(91)90557-B","volume":"193","author":"F Peracchia","year":"1991","unstructured":"Peracchia F, Ferrari G, Poggi A, Rotilio D. IL-1 beta-induced expression of PDGF-AA isoform in rabbit articular chondrocytes is modulated by TGF-beta 1. Exp Cell Res. 1991;193(1):208\u201312.","journal-title":"Exp Cell Res"},{"issue":"10","key":"4119_CR35","doi-asserted-by":"crossref","first-page":"17946","DOI":"10.1002\/jcp.28427","volume":"234","author":"Z Yao","year":"2019","unstructured":"Yao Z, Chen P, Wang S, Deng G, Hu Y, Lin Q, Zhang X, Yu B. Reduced PDGF-AA in subchondral bone leads to articular cartilage degeneration after strenuous running. J Cell Physiol. 2019;234(10):17946\u201358.","journal-title":"J Cell Physiol"},{"issue":"3","key":"4119_CR36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cellsig.2011.11.001","volume":"24","author":"M Razmara","year":"2012","unstructured":"Razmara M, Eger G, Rorsman C, Heldin CH, Lennartsson J. MKP3 negatively modulates PDGF-induced Akt and Erk5 phosphorylation as well as chemotaxis. Cell Signal. 2012;24(3):635\u201340.","journal-title":"Cell Signal"},{"key":"4119_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2019.05.012","volume":"1719","author":"LL Xiong","year":"2019","unstructured":"Xiong LL, Xue LL, Jiang Y, Ma Z, Jin Y, Wang YC, Wang YY, Xia QJ, Zhang Y, Hu Q, et al. Suppression of PDGF induces neuronal apoptosis after neonatal cerebral hypoxia and ischemia by inhibiting P-PI3K and P-AKT signaling pathways. Brain Res. 2019;1719:77\u201388.","journal-title":"Brain Res"},{"issue":"3","key":"4119_CR38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jor.2019.02.028","volume":"16","author":"I Setiawan","year":"2019","unstructured":"Setiawan I, Suyasa IK, Astawa P, Dusak IWS, Kawiyana IKS, Aryana I. Recombinant platelet derived growth factor-BB and hyaluronic acid effect in rat osteoarthritis models. J Orthop. 2019;16(3):230\u20133.","journal-title":"J Orthop"},{"issue":"8","key":"4119_CR39","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.joca.2018.05.009","volume":"26","author":"K Kisand","year":"2018","unstructured":"Kisand K, Tamm AE, Lintrop M, Tamm AO. New insights into the natural course of knee osteoarthritis: early regulation of cytokines and growth factors, with emphasis on sex-dependent angiogenesis and tissue remodeling. A Pilot Study Osteoarth Cartil. 2018;26(8):1045\u201354.","journal-title":"A Pilot Study Osteoarth Cartil"},{"key":"4119_CR40","doi-asserted-by":"publisher","unstructured":"Su W, Liu G, Liu X, Zhou Y, Sun Q, Zhen G, Wang X, Hu Y, Gao P, Demehri S, Cao X. Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development. JCI Insight 2020;5(8):e135446. https:\/\/doi.org\/10.1172\/jci.insight.135446.","DOI":"10.1172\/jci.insight.135446"},{"key":"4119_CR41","doi-asserted-by":"crossref","first-page":"685665","DOI":"10.3389\/fcell.2021.685665","volume":"9","author":"HE Abud","year":"2021","unstructured":"Abud HE, Chan WH, Jard\u00e9 T. Source and impact of the EGF family of ligands on intestinal stem cells. Front Cell Develop Biol. 2021;9:685665.","journal-title":"Front Cell Develop Biol"},{"key":"4119_CR42","doi-asserted-by":"crossref","first-page":"8739473","DOI":"10.1155\/2018\/8739473","volume":"2018","author":"S Rayego-Mateos","year":"2018","unstructured":"Rayego-Mateos S, Rodrigues-Diez R, Morgado-Pascual JL, Valentijn F, Valdivielso JM, Goldschmeding R, Ruiz-Ortega M. Role of epidermal growth factor receptor (EGFR) and Its ligands in kidney inflammation and damage. Med Inflamm. 2018;2018:8739473.","journal-title":"Med Inflamm"},{"issue":"10","key":"4119_CR43","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cellsig.2005.03.026","volume":"17","author":"AB Singh","year":"2005","unstructured":"Singh AB, Harris RC. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal. 2005;17(10):1183\u201393.","journal-title":"Cell Signal"},{"key":"4119_CR44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fncel.2013.00004","volume":"7","author":"Y Iwakura","year":"2013","unstructured":"Iwakura Y, Nawa H. ErbB1-4-dependent EGF\/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson\u2019s disease. Front Cell Neurosci. 2013;7:4.","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"4119_CR45","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.joca.2015.04.019","volume":"23","author":"DL Long","year":"2015","unstructured":"Long DL, Ulici V, Chubinskaya S, Loeser RF. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities. Osteoarth Cartil. 2015;23(9):1523\u201331.","journal-title":"Osteoarth Cartil"},{"issue":"50","key":"4119_CR46","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.1073\/pnas.1608938113","volume":"113","author":"H Jia","year":"2016","unstructured":"Jia H, Ma X, Tong W, Doyran B, Sun Z, Wang L, Zhang X, Zhou Y, Badar F, Chandra A, et al. EGFR signaling is critical for maintaining the superficial layer of articular cartilage and preventing osteoarthritis initiation. Proc Natl Acad Sci USA. 2016;113(50):14360\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"4119_CR47","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/art.38758","volume":"66","author":"MA Pest","year":"2014","unstructured":"Pest MA, Russell BA, Zhang YW, Jeong JW, Beier F. Disturbed cartilage and joint homeostasis resulting from a loss of mitogen-inducible gene 6 in a mouse model of joint dysfunction. Arthritis Rheumatol. 2014;66(10):2816\u201327.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"4119_CR48","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar4233","volume":"15","author":"JB Shepard","year":"2013","unstructured":"Shepard JB, Jeong JW, Maihle NJ, O\u2019Brien S, Dealy CN. Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo. Arthritis Res Ther. 2013;15(3):R60.","journal-title":"Arthritis Res Ther"},{"issue":"576","key":"4119_CR49","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1126\/scitranslmed.abb3946","volume":"13","author":"Y Wei","year":"2021","unstructured":"Wei Y, Luo L, Gui T, Yu F, Yan L, Yao L, Zhong L, Yu W, Han B, Patel JM, et al. Targeting cartilage EGFR pathway for osteoarthritis treatment. Sci Trans Med. 2021;13(576):3946.","journal-title":"Sci Trans Med"},{"issue":"5","key":"4119_CR50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/mp.54.5.311","volume":"54","author":"Z Laron","year":"2001","unstructured":"Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol: MP. 2001;54(5):311\u20136.","journal-title":"Mol Pathol: MP"},{"issue":"4763","key":"4119_CR51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.3523759","volume":"233","author":"A Nilsson","year":"1986","unstructured":"Nilsson A, Isgaard J, Lindahl A, Dahlstr\u00f6m A, Skottner A, Isaksson OG. Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate. Science. 1986;233(4763):571\u20134.","journal-title":"Science"},{"issue":"1","key":"4119_CR52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.joca.2008.05.007","volume":"17","author":"M Zhang","year":"2009","unstructured":"Zhang M, Zhou Q, Liang QQ, Li CG, Holz JD, Tang D, Sheu TJ, Li TF, Shi Q, Wang YJ. IGF-1 regulation of type II collagen and MMP-13 expression in rat endplate chondrocytes via distinct signaling pathways. Osteoarth Cartil. 2009;17(1):100\u20136.","journal-title":"Osteoarth Cartil"},{"key":"4119_CR53","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.2147\/JIR.S316756","volume":"14","author":"MA Hossain","year":"2021","unstructured":"Hossain MA, Adithan A, Alam MJ, Kopalli SR, Kim B, Kang CW, Hwang KC, Kim JH. IGF-1 facilitates cartilage reconstruction by regulating PI3K\/AKT, MAPK, and NF-kB signaling in rabbit osteoarthritis. J Inflamm Res. 2021;14:3555\u201368.","journal-title":"J Inflamm Res"},{"issue":"2","key":"4119_CR54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.joca.2011.11.012","volume":"20","author":"KM Claessen","year":"2012","unstructured":"Claessen KM, Ramautar SR, Pereira AM, Smit JW, Biermasz NR, Kloppenburg M. Relationship between insulin-like growth factor-1 and radiographic disease in patients with primary osteoarthritis: a systematic review. Osteoarth Cartil. 2012;20(2):79\u201386.","journal-title":"Osteoarth Cartil"},{"issue":"12","key":"4119_CR55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.55.12.870","volume":"55","author":"ME Lloyd","year":"1996","unstructured":"Lloyd ME, Hart DJ, Nandra D, McAlindon TE, Wheeler M, Doyle DV, Spector TD. Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study. Ann Rheum Dis. 1996;55(12):870\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4119_CR56","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keaa597","volume":"60","author":"A Hartley","year":"2021","unstructured":"Hartley A, Sanderson E, Paternoster L, Teumer A, Kaplan RC, Tobias JH, Gregson CL. Mendelian randomization provides evidence for a causal effect of higher serum IGF-1 concentration on risk of hip and knee osteoarthritis. Rheumatology. 2021;60(4):1676\u201386.","journal-title":"Rheumatology"},{"issue":"9","key":"4119_CR57","first-page":"1217","volume":"17","author":"CW Denko","year":"1990","unstructured":"Denko CW, Boja B, Moskowitz RW. Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. J Rheumatol. 1990;17(9):1217\u201321.","journal-title":"J Rheumatol"},{"issue":"4","key":"4119_CR58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1063-4584(05)80102-5","volume":"4","author":"CW Denko","year":"1996","unstructured":"Denko CW, Boja B, Moskowitz RW. Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders. Osteoarth Cartil. 1996;4(4):245\u20139.","journal-title":"Osteoarth Cartil"},{"key":"4119_CR59","doi-asserted-by":"crossref","first-page":"111052","DOI":"10.1016\/j.mce.2020.111052","volume":"519","author":"M Dixit","year":"2021","unstructured":"Dixit M, Poudel SB, Yakar S. Effects of GH\/IGF axis on bone and cartilage. Mol Cell Endocrinol. 2021;519:111052.","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"4119_CR60","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1242\/dev.01053","volume":"131","author":"E Zelzer","year":"2004","unstructured":"Zelzer E, Mamluk R, Ferrara N, Johnson RS, Schipani E, Olsen BR. VEGFA is necessary for chondrocyte survival during bone development. Development. 2004;131(9):2161\u201371.","journal-title":"Development"},{"issue":"3","key":"4119_CR61","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jbmr.1487","volume":"27","author":"C Maes","year":"2012","unstructured":"Maes C, Araldi E, Haigh K, Khatri R, Van Looveren R, Giaccia AJ, Haigh JJ, Carmeliet G, Schipani E. VEGF-independent cell-autonomous functions of HIF-1\u03b1 regulating oxygen consumption in fetal cartilage are critical for chondrocyte survival. J Bone Min Res: Off J Am Soc Bone Min Res. 2012;27(3):596\u2013609.","journal-title":"J Bone Min Res: Off J Am Soc Bone Min Res"},{"issue":"11","key":"4119_CR62","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1242\/dev.117952","volume":"142","author":"X Duan","year":"2015","unstructured":"Duan X, Murata Y, Liu Y, Nicolae C, Olsen BR, Berendsen AD. Vegfa regulates perichondrial vascularity and osteoblast differentiation in bone development. Development. 2015;142(11):1984\u201391.","journal-title":"Development"},{"issue":"5","key":"4119_CR63","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jbmr.2828","volume":"31","author":"JL Hamilton","year":"2016","unstructured":"Hamilton JL, Nagao M, Levine BR, Chen D, Olsen BR, Im HJ. Targeting VEGF and Its receptors for the treatment of osteoarthritis and associated pain. J Bone Min Res: Off J Am Soc Bone Min Res. 2016;31(5):911\u201324.","journal-title":"J Bone Min Res: Off J Am Soc Bone Min Res"},{"issue":"6","key":"4119_CR64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669\u201376.","journal-title":"Nat Med"},{"issue":"5","key":"4119_CR65","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"AK Olsson","year":"2006","unstructured":"Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"4119_CR66","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/rheumatology\/keq188","volume":"49","author":"DA Walsh","year":"2010","unstructured":"Walsh DA, McWilliams DF, Turley MJ, Dixon MR, Frans\u00e8s RE, Mapp PI, Wilson D. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology. 2010;49(10):1852\u201361.","journal-title":"Rheumatology"},{"issue":"4","key":"4119_CR67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.joca.2009.11.015","volume":"18","author":"RE Frans\u00e8s","year":"2010","unstructured":"Frans\u00e8s RE, McWilliams DF, Mapp PI, Walsh DA. Osteochondral angiogenesis and increased protease inhibitor expression in OA. Osteoarth Cartil. 2010;18(4):563\u201371.","journal-title":"Osteoarth Cartil"},{"issue":"7","key":"4119_CR68","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.joca.2007.01.020","volume":"15","author":"DA Walsh","year":"2007","unstructured":"Walsh DA, Bonnet CS, Turner EL, Wilson D, Situ M, McWilliams DF. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarth Cartil. 2007;15(7):743\u201351.","journal-title":"Osteoarth Cartil"},{"issue":"8","key":"4119_CR69","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/art.11094","volume":"48","author":"L Haywood","year":"2003","unstructured":"Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum. 2003;48(8):2173\u20137.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4119_CR70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/path.842","volume":"194","author":"A Giatromanolaki","year":"2001","unstructured":"Giatromanolaki A, Sivridis E, Athanassou N, Zois E, Thorpe PE, Brekken RA, Gatter KC, Harris AL, Koukourakis IM, Koukourakis MI. The angiogenic pathway \u201cvascular endothelial growth factor\/flk-1(KDR)-receptor\u201d in rheumatoid arthritis and osteoarthritis. J Pathol. 2001;194(1):101\u20138.","journal-title":"J Pathol"},{"issue":"10","key":"4119_CR71","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.27608","volume":"62","author":"HJ Im","year":"2010","unstructured":"Im HJ, Kim JS, Li X, Kotwal N, Sumner DR, van Wijnen AJ, Davis FJ, Yan D, Levine B, Henry JL, et al. Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum. 2010;62(10):2995\u20133005.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4119_CR72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/ard.2010.137844","volume":"70","author":"S Ashraf","year":"2011","unstructured":"Ashraf S, Wibberley H, Mapp PI, Hill R, Wilson D, Walsh DA. Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis. Ann Rheum Dis. 2011;70(3):523\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4119_CR73","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13075-014-0427-y","volume":"16","author":"T Nagai","year":"2014","unstructured":"Nagai T, Sato M, Kobayashi M, Yokoyama M, Tani Y, Mochida J. Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis. Arthritis Res Ther. 2014;16(5):427.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"4119_CR74","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1039\/D1BM01873F","volume":"10","author":"JS Lee","year":"2022","unstructured":"Lee JS, Guo P, Klett K, Hall M, Sinha K, Ravuri S, Huard J, Murphy WL. VEGF-attenuated platelet-rich plasma improves therapeutic effect on cartilage repair. Biomater Sci. 2022;10(9):2172\u201381.","journal-title":"Biomater Sci"},{"key":"4119_CR75","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.cb.09.110193.001533","volume":"9","author":"KJ Tracey","year":"1993","unstructured":"Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol. 1993;9:317\u201343.","journal-title":"Annu Rev Cell Biol"},{"key":"4119_CR76","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.med.45.1.491","volume":"45","author":"KJ Tracey","year":"1994","unstructured":"Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491\u2013503.","journal-title":"Annu Rev Med"},{"key":"4119_CR77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","volume":"44","author":"T Wang","year":"2018","unstructured":"Wang T, He C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38\u201350.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"4119_CR78","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0736-0266(01)00088-2","volume":"20","author":"JC Clohisy","year":"2002","unstructured":"Clohisy JC, Teitelbaum S, Chen S, Erdmann JM, Abu-Amer Y. Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. J Orthop Res: Off Publ Orthop Res Soc. 2002;20(2):174\u201381.","journal-title":"J Orthop Res: Off Publ Orthop Res Soc"},{"issue":"1","key":"4119_CR79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9440(10)65266-2","volume":"154","author":"KD Merkel","year":"1999","unstructured":"Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol. 1999;154(1):203\u201310.","journal-title":"Am J Pathol"},{"issue":"6","key":"4119_CR80","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2106\/00004623-199306000-00007","volume":"75","author":"WA Jiranek","year":"1993","unstructured":"Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, Harris WH. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am. 1993;75(6):863\u201379.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"4119_CR81","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar1464","volume":"7","author":"AR Klooster","year":"2005","unstructured":"Klooster AR, Bernier SM. Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Res Ther. 2005;7(1):R127-138.","journal-title":"Arthritis Res Ther"},{"issue":"427","key":"4119_CR82","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.blo.0000144854.66565.8f","volume":"1","author":"SR Goldring","year":"2004","unstructured":"Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Related Res. 2004;1(427):S27-36.","journal-title":"Clin Orthop Related Res"},{"issue":"5","key":"4119_CR83","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1074\/jbc.275.5.3687","volume":"275","author":"S Murakami","year":"2000","unstructured":"Murakami S, Lefebvre V, de Crombrugghe B. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem. 2000;275(5):3687\u201392.","journal-title":"J Biol Chem"},{"issue":"10","key":"4119_CR84","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.joca.2006.03.008","volume":"14","author":"MJ L\u00f3pez-Armada","year":"2006","unstructured":"L\u00f3pez-Armada MJ, Caram\u00e9s B, Mart\u00edn MA, Cillero-Pastor B, Lires-Dean M, Fuentes-Boquete I, Arenas J, Blanco FJ. Mitochondrial activity is modulated by TNFalpha and IL-1beta in normal human chondrocyte cells. Osteoarth Cartil. 2006;14(10):1011\u201322.","journal-title":"Osteoarth Cartil"},{"issue":"2","key":"4119_CR85","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1139\/cjpp-2013-0228","volume":"92","author":"Z Ye","year":"2014","unstructured":"Ye Z, Chen Y, Zhang R, Dai H, Zeng C, Zeng H, Feng H, Du G, Fang H, Cai D. c-Jun N-terminal kinase - c-Jun pathway transactivates Bim to promote osteoarthritis. Can J Physiol Pharmacol. 2014;92(2):132\u20139.","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"4119_CR86","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jcp.10371","volume":"197","author":"CA S\u00e9guin","year":"2003","unstructured":"S\u00e9guin CA, Bernier SM. TNFalpha suppresses link protein and type II collagen expression in chondrocytes: role of MEK1\/2 and NF-kappaB signaling pathways. J Cell Physiol. 2003;197(3):356\u201369.","journal-title":"J Cell Physiol"},{"issue":"9","key":"4119_CR87","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1021\/jf1046738","volume":"59","author":"YC Lu","year":"2011","unstructured":"Lu YC, Jayakumar T, Duann YF, Chou YC, Hsieh CY, Yu SY, Sheu JR, Hsiao G. Chondroprotective role of sesamol by inhibiting MMPs expression via retaining NF-\u03baB signaling in activated SW1353 cells. J Agric Food Chem. 2011;59(9):4969\u201378.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"4119_CR88","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exger.2010.09.014","volume":"46","author":"GV Halade","year":"2011","unstructured":"Halade GV, El Jamali A, Williams PJ, Fajardo RJ, Fernandes G. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp Gerontol. 2011;46(1):43\u201352.","journal-title":"Exp Gerontol"},{"issue":"1","key":"4119_CR89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","volume":"69","author":"HS Park","year":"2005","unstructured":"Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69(1):29\u201335.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"4119_CR90","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Investig. 2005;115(5):1111\u20139.","journal-title":"J Clin Investig"},{"issue":"2","key":"4119_CR91","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2478\/v10039-009-0035-2","volume":"54","author":"M Gnaci\u0144ska","year":"2009","unstructured":"Gnaci\u0144ska M, Ma\u0142gorzewicz S, Stojek M, \u0141ysiak-Szyd\u0142owska W, Sworczak K. Role of adipokines in complications related to obesity: a review. Adv Med Sci. 2009;54(2):150\u20137.","journal-title":"Adv Med Sci"},{"issue":"12","key":"4119_CR92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11926-019-0868-z","volume":"21","author":"C Xie","year":"2019","unstructured":"Xie C, Chen Q. Adipokines: new therapeutic target for osteoarthritis? Curr Rheumatol Rep. 2019;21(12):71.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"4119_CR93","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/mvre.1999.2179","volume":"58","author":"AJ Hayes","year":"1999","unstructured":"Hayes AJ, Huang WQ, Mallah J, Yang D, Lippman ME, Li LY. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res. 1999;58(3):224\u201337.","journal-title":"Microvasc Res"},{"issue":"8","key":"4119_CR94","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/j.0022-0337.2002.66.8.tb03565.x","volume":"66","author":"PJ Polverini","year":"2002","unstructured":"Polverini PJ. Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. J Dent Educ. 2002;66(8):962\u201375.","journal-title":"J Dent Educ"},{"issue":"2","key":"4119_CR95","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/ar3771","volume":"14","author":"C Lambert","year":"2012","unstructured":"Lambert C, Mathy-Hartert M, Dubuc JE, Montell E, Verg\u00e9s J, Munaut C, No\u00ebl A, Henrotin Y. Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Res Ther. 2012;14(2):R58.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4119_CR96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.trsl.2006.12.007","volume":"149","author":"T Kasama","year":"2007","unstructured":"Kasama T, Isozaki T, Odai T, Matsunawa M, Wakabayashi K, Takeuchi HT, Matsukura S, Adachi M, Tezuka M, Kobayashi K. Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma. Trans Res: J Lab Clin Med. 2007;149(5):265\u201373.","journal-title":"Trans Res: J Lab Clin Med"},{"key":"4119_CR97","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1189\/jlb.70.3.465","volume":"70","author":"K Bacon","year":"2001","unstructured":"Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, Matsushima K, Murphy P, Nomiyama H, Oppenheim J, Rot A. Chemokine\/chemokine receptor nomenclature. J Leukoc Biol. 2001;70:465\u20136.","journal-title":"J Leukoc Biol"},{"issue":"42","key":"4119_CR98","doi-asserted-by":"crossref","first-page":"35760","DOI":"10.1074\/jbc.M508234200","volume":"280","author":"K Balabanian","year":"2005","unstructured":"Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F. The chemokine SDF-1\/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem. 2005;280(42):35760\u20136.","journal-title":"J Biol Chem"},{"issue":"3","key":"4119_CR99","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.joca.2020.10.010","volume":"29","author":"J Li","year":"2021","unstructured":"Li J, Chen H, Zhang D, Xie J, Zhou X. The role of stromal cell-derived factor 1 on cartilage development and disease. Osteoarth Cartil. 2021;29(3):313\u201322.","journal-title":"Osteoarth Cartil"},{"issue":"6","key":"4119_CR100","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.joca.2015.01.016","volume":"23","author":"GW Kim","year":"2015","unstructured":"Kim GW, Han MS, Park HR, Lee EJ, Jung YK, Usmani SE, Ulici V, Han SW, Beier F. CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation. Osteoarth Cartil. 2015;23(6):966\u201374.","journal-title":"Osteoarth Cartil"},{"issue":"3","key":"4119_CR101","first-page":"2231","volume":"19","author":"Y Dai","year":"2019","unstructured":"Dai Y, Liu S, Xie X, Ding M, Zhou Q, Zhou X. MicroRNA-31 promotes chondrocyte proliferation by targeting C-X-C motif chemokine ligand 12. Mol Med Rep. 2019;19(3):2231\u20137.","journal-title":"Mol Med Rep"},{"issue":"6","key":"4119_CR102","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00109-017-1516-6","volume":"95","author":"X Zheng","year":"2017","unstructured":"Zheng X, Zhao FC, Pang Y, Li DY, Yao SC, Sun SS, Guo KJ. Downregulation of miR-221-3p contributes to IL-1\u03b2-induced cartilage degradation by directly targeting the SDF1\/CXCR4 signaling pathway. J Mol Med. 2017;95(6):615\u201327.","journal-title":"J Mol Med"},{"issue":"6","key":"4119_CR103","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2310\/JIM.0b013e31825f9f69","volume":"60","author":"Q Xu","year":"2012","unstructured":"Xu Q, Sun XC, Shang XP, Jiang HS. Association of CXCL12 levels in synovial fluid with the radiographic severity of knee osteoarthritis. J Invest Med: Off Publ Am Federation for Clinical Research. 2012;60(6):898\u2013901.","journal-title":"J Invest Med: Off Publ Am Federation for Clinical Research"},{"issue":"1","key":"4119_CR104","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D","volume":"46","author":"K Kanbe","year":"2002","unstructured":"Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum. 2002;46(1):130\u20137.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4119_CR105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.joca.2006.01.007","volume":"14","author":"SW Jones","year":"2006","unstructured":"Jones SW, Brockbank SM, Mobbs ML, Le Good NJ, Soma-Haddrick S, Heuze AJ, Langham CJ, Timms D, Newham P, Needham MR. The orphan G-protein coupled receptor RDC1: evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover. Osteoarth Cartil. 2006;14(6):597\u2013608.","journal-title":"Osteoarth Cartil"},{"key":"4119_CR106","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3389\/fphar.2019.01554","volume":"10","author":"W Lu","year":"2019","unstructured":"Lu W, He Z, Shi J, Wang Z, Wu W, Liu J, Kang H, Li F, Liang S. AMD3100 attenuates post-traumatic osteoarthritis by maintaining transforming growth factor-\u03b21-induced expression of tissue inhibitor of metalloproteinase-3 via the phosphatidylinositol 3-kinase\/akt pathway. Front Pharmacol. 2019;10:1554.","journal-title":"Front Pharmacol"},{"issue":"10","key":"4119_CR107","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/ijms17101522","volume":"17","author":"W Lu","year":"2016","unstructured":"Lu W, Shi J, Zhang J, Lv Z, Guo F, Huang H, Zhu W, Chen A. CXCL12\/CXCR4 axis regulates aggrecanase activation and cartilage degradation in a post-traumatic osteoarthritis rat model. Int J Mol Sci. 2016;17(10):1522.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4119_CR108","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jcp.20435","volume":"206","author":"G Lisignoli","year":"2006","unstructured":"Lisignoli G, Toneguzzi S, Piacentini A, Cristino S, Grassi F, Cavallo C, Facchini A. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol. 2006;206(1):78\u201385.","journal-title":"J Cell Physiol"},{"issue":"6","key":"4119_CR109","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.joca.2017.01.008","volume":"25","author":"Y Chen","year":"2017","unstructured":"Chen Y, Lin S, Sun Y, Guo J, Lu Y, Suen CW, Zhang J, Zha Z, Ho KW, Pan X, et al. Attenuation of subchondral bone abnormal changes in osteoarthritis by inhibition of SDF-1 signaling. Osteoarth Cartil. 2017;25(6):986\u201394.","journal-title":"Osteoarth Cartil"},{"key":"4119_CR110","first-page":"8852574","volume":"2021","author":"H Qin","year":"2021","unstructured":"Qin H, Zhao X, Hu YJ, Wang S, Ma Y, He S, Shen K, Wan H, Cui Z, Yu B. Inhibition of SDF-1\/CXCR4 axis to alleviate abnormal bone formation and angiogenesis could improve the subchondral bone microenvironment in osteoarthritis. Biomed Res Int. 2021;2021:8852574.","journal-title":"Biomed Res Int"},{"key":"4119_CR111","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.actbio.2021.03.013","volume":"126","author":"AR Martin","year":"2021","unstructured":"Martin AR, Patel JM, Locke RC, Eby MR, Saleh KS, Davidson MD, Sennett ML, Zlotnick HM, Chang AH, Carey JL, et al. Nanofibrous hyaluronic acid scaffolds delivering TGF-\u03b23 and SDF-1\u03b1 for articular cartilage repair in a large animal model. Acta Biomater. 2021;126:170\u201382.","journal-title":"Acta Biomater"},{"issue":"7","key":"4119_CR112","first-page":"1374","volume":"39","author":"M Tu","year":"2019","unstructured":"Tu M, Yao Y, Qiao FH, Wang L. The pathogenic role of connective tissue growth factor in osteoarthritis. Biosci Rep. 2019;39(7):1374.","journal-title":"Biosci Rep"},{"issue":"10","key":"4119_CR113","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tem.2009.07.002","volume":"20","author":"RC Baxter","year":"2009","unstructured":"Baxter RC, Twigg SM. Actions of IGF binding proteins and related proteins in adipose tissue. Trends Endocrinol Metab. 2009;20(10):499\u2013505.","journal-title":"Trends Endocrinol Metab"},{"key":"4119_CR114","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fphys.2018.00644","volume":"9","author":"H Bazzazi","year":"2018","unstructured":"Bazzazi H, Zhang Y, Jafarnejad M, Isenberg JS, Annex BH, Popel AS. Computer simulation of TSP1 inhibition of VEGF-Akt-eNOS: an angiogenesis triple threat. Front Physiol. 2018;9:644.","journal-title":"Front Physiol"},{"issue":"6","key":"4119_CR115","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ajpath.2011.02.039","volume":"178","author":"A Lu","year":"2011","unstructured":"Lu A, Miao M, Schoeb TR, Agarwal A, Murphy-Ullrich JE. Blockade of TSP1-dependent TGF-\u03b2 activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am J Pathol. 2011;178(6):2573\u201386.","journal-title":"Am J Pathol"},{"issue":"10","key":"4119_CR116","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.joca.2004.06.009","volume":"12","author":"S Omoto","year":"2004","unstructured":"Omoto S, Nishida K, Yamaai Y, Shibahara M, Nishida T, Doi T, Asahara H, Nakanishi T, Inoue H, Takigawa M. Expression and localization of connective tissue growth factor (CTGF\/Hcs24\/CCN2) in osteoarthritic cartilage. Osteoarth Cartil. 2004;12(10):771\u20138.","journal-title":"Osteoarth Cartil"},{"issue":"5","key":"4119_CR117","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/art.21795","volume":"54","author":"EN Blaney Davidson","year":"2006","unstructured":"Blaney Davidson EN, Vitters EL, Mooren FM, Oliver N, Berg WB, van der Kraan PM. Connective tissue growth factor\/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum. 2006;54(5):1653\u201361.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4119_CR118","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1042\/BST20180004","volume":"46","author":"B Farrell","year":"2018","unstructured":"Farrell B, Breeze AL. Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting. Biochem Soc Trans. 2018;46(6):1753\u201370.","journal-title":"Biochem Soc Trans"},{"issue":"15","key":"4119_CR119","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1074\/jbc.M609040200","volume":"282","author":"HJ Im","year":"2007","unstructured":"Im HJ, Muddasani P, Natarajan V, Schmid TM, Block JA, Davis F, van Wijnen AJ, Loeser RF. Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase Cdelta pathways in human adult articular chondrocytes. J Biol Chem. 2007;282(15):11110\u201321.","journal-title":"J Biol Chem"},{"issue":"4","key":"4119_CR120","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar3441","volume":"13","author":"D Yan","year":"2011","unstructured":"Yan D, Chen D, Cool SM, van Wijnen AJ, Mikecz K, Murphy G, Im HJ. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes. Arthritis Res Ther. 2011;13(4):R130.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"4119_CR121","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1002\/art.34645","volume":"64","author":"T Weng","year":"2012","unstructured":"Weng T, Yi L, Huang J, Luo F, Wen X, Du X, Chen Q, Deng C, Chen D, Chen L. Genetic inhibition of fibroblast growth factor receptor 1 in knee cartilage attenuates the degeneration of articular cartilage in adult mice. Arthritis Rheum. 2012;64(12):3982\u201392.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"4119_CR122","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.39739","volume":"68","author":"J Tang","year":"2016","unstructured":"Tang J, Su N, Zhou S, Xie Y, Huang J, Wen X, Wang Z, Wang Q, Xu W, Du X, et al. Fibroblast growth factor receptor 3 inhibits osteoarthritis progression in the knee joints of adult mice. Arthritis Rheumatol. 2016;68(10):2432\u201343.","journal-title":"Arthritis Rheumatol"},{"key":"4119_CR123","doi-asserted-by":"crossref","first-page":"24039","DOI":"10.1038\/srep24039","volume":"6","author":"S Zhou","year":"2016","unstructured":"Zhou S, Xie Y, Li W, Huang J, Wang Z, Tang J, Xu W, Sun X, Tan Q, Huang S, et al. Conditional deletion of Fgfr3 in chondrocytes leads to osteoarthritis-like defects in temporomandibular joint of adult mice. Sci Rep. 2016;6:24039.","journal-title":"Sci Rep"},{"issue":"1","key":"4119_CR124","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/annrheumdis-2019-215696","volume":"79","author":"L Kuang","year":"2020","unstructured":"Kuang L, Wu J, Su N, Qi H, Chen H, Zhou S, Xiong Y, Du X, Tan Q, Yang J, et al. FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice. Ann Rheum Dis. 2020;79(1):112\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4119_CR125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, et al. FGF\/FGFR signaling in health and disease. Signal Transduct Target Ther. 2020;5(1):181.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"4119_CR126","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41584-020-0469-2","volume":"16","author":"Y Xie","year":"2020","unstructured":"Xie Y, Zinkle A, Chen L, Mohammadi M. Fibroblast growth factor signalling in osteoarthritis and cartilage repair. Nat Rev Rheumatol. 2020;16(10):547\u201364.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"4119_CR127","first-page":"1772","volume":"28","author":"M Nagashima","year":"2001","unstructured":"Nagashima M, Hasegawa J, Kato K, Yamazaki J, Nishigai K, Ishiwata T, Asano G, Yoshino S. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis. J Rheumatol. 2001;28(8):1772\u20138.","journal-title":"J Rheumatol"},{"issue":"3","key":"4119_CR128","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(84)91253-1","volume":"122","author":"T Nakamura","year":"1984","unstructured":"Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122(3):1450\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4119_CR129","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1074\/jbc.271.7.3615","volume":"271","author":"K Miyazawa","year":"1996","unstructured":"Miyazawa K, Shimomura T, Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem. 1996;271(7):3615\u20138.","journal-title":"J Biol Chem"},{"issue":"15","key":"4119_CR130","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1073\/pnas.86.15.5844","volume":"86","author":"E Gherardi","year":"1989","unstructured":"Gherardi E, Gray J, Stoker M, Perryman M, Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA. 1989;86(15):5844\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"4119_CR131","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00264-014-2406-y","volume":"38","author":"T Mabey","year":"2014","unstructured":"Mabey T, Honsawek S, Saetan N, Poovorawan Y, Tanavalee A, Yuktanandana P. Angiogenic cytokine expression profiles in plasma and synovial fluid of primary knee osteoarthritis. Int Orthop. 2014;38(9):1885\u201392.","journal-title":"Int Orthop"},{"issue":"3","key":"4119_CR132","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2164\/jandrol.109.007658","volume":"31","author":"A Catizone","year":"2010","unstructured":"Catizone A, Ricci G, Tufano MA, Perfetto B, Canipari R, Galdieri M. Hepatocyte growth factor (HGF) modulates Leydig cell extracellular matrix components. J Androl. 2010;31(3):306\u201313.","journal-title":"J Androl"},{"issue":"1","key":"4119_CR133","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-022-02893-9","volume":"24","author":"W Que","year":"2022","unstructured":"Que W, Liu H, Yang Q. CircPRKCH modulates extracellular matrix formation and metabolism by regulating the miR-145\/HGF axis in osteoarthritis. Arthritis Res Ther. 2022;24(1):216.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"4119_CR134","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s13287-020-02005-x","volume":"11","author":"Y Huang","year":"2020","unstructured":"Huang Y, He B, Wang L, Yuan B, Shu H, Zhang F, Sun L. Bone marrow mesenchymal stem cell-derived exosomes promote rotator cuff tendon-bone healing by promoting angiogenesis and regulating M1 macrophages in rats. Stem Cell Res Ther. 2020;11(1):496.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4119_CR135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jse.2017.08.007","volume":"27","author":"KC Noh","year":"2018","unstructured":"Noh KC, Park SH, Yang CJ, Lee GW, Kim MK, Kang YH. Involvement of synovial matrix degradation and angiogenesis in oxidative stress-exposed degenerative rotator cuff tears with osteoarthritis. J Shoulder Elbow Surg. 2018;27(1):141\u201350.","journal-title":"J Shoulder Elbow Surg"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-04119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-04119-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-04119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T03:10:05Z","timestamp":1700277005000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-04119-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4119"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-04119-3","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"713"}}